Aclidinium bromide/formoterol
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 21:45, 27 August 2017. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 21:45, 27 August 2017 by Vanished user 0x8cSXE0x6 (talk | contribs)
| Combination of | |
|---|---|
| Aclidinium bromide | Long-acting muscarinic antagonist |
| Formoterol | Long-acting β2 agonist |
| Clinical data | |
| Trade names | Brimica Genuair, Duaklir Genuair |
| AHFS/Drugs.com | UK Drug Information |
| Routes of administration | Inhalation |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
Aclidinium/formoterol (trade names Duaklir and Brimica) is a combination drug for inhalation, used in the management of chronic obstructive pulmonary disease (COPD). It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β2 agonist.[1]
References
- ^ "Duaklir Genuair". European Medicines Agency. 2014-12-05. Retrieved 2015-06-01.
| α1 |
| ||||
|---|---|---|---|---|---|
| α2 |
| ||||
| β |
| ||||
| mAChRsTooltip Muscarinic acetylcholine receptors |
| ||||
|---|---|---|---|---|---|
| Precursors (and prodrugs) | |||||
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Drugs with non-standard legal status
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- All stub articles